Ghisallo Capital Management »

Bright Minds Biosciences shares owned by Ghisallo Capital Management

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by Ghisallo Capital Management from 13F filings

Historical chart of Ghisallo Capital Management investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by Ghisallo Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by Ghisallo Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $803k 11k 72.97

More positions owned by Ghisallo Capital Management

Medline Com Cl A (MDLN)
Xpeng Ads (XPEV)
Hyuhi 05/04/31 Cvt Put Convertible Bond
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Ztoec 0.925 03/01/31 Cvt Put Convertible Bond
Microsoft Corporation (MSFT)
Wiwynn 04/01/31 Convertible Bond
Chpac 09/18/30 Cvt Put Convertible Bond
Globalfoundries Ordinary Shares (GFS)
Trane Technologies SHS (TT)
Johnson Controls Internation SHS (JCI)
Nipst 02/14/29 Cvt Convertible Bond
Oracle Corporation (ORCL)
Bltiv 02/05/33 Cvt Put Convertible Bond (JTGLF)

View all positions for Ghisallo Capital Management

Top funds holding Bright Minds Biosciences

Henderson Group
Cormorant Asset Management
BlackRock
Vivo Capital
Braidwell
Vestal Point Capital
Adage Capital Partners GP
Perceptive Advisors
Balyasny Asset Management
Deerfield Management Company
Driehaus Capital Management
RA Capital Management
Dr. Jeffrey R. Jay, M.D.
MPM Oncology Impact Management
Ikarian Capital

View all funds holding Bright Minds Biosciences